Petra Ross-Macdonald

5PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 16, 2022
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy.

John-William Sidhom, Giacomo Oliveira, Petra Ross-MacDonald

|Mar 19, 2022
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma.

Robert J Motzer, Toni K Choueiri, David F McDermott

|Feb 08, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumab.

Kathleen M Mahoney, Petra Ross-Macdonald, Long Yuan

|Jul 07, 2021
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.

Oscar Krijgsman, Kristel Kemper, Julia Boshuizen

|Mar 04, 2021
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.

Petra Ross-Macdonald, Alice M Walsh, Scott D Chasalow

Pageof 1